Literature DB >> 29754496

Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.

Eun Soo Kim1, Dae Young Yoon2, Ji Yoon Moon2, Sora Baek3, You Mie Han4, Young Lan Seo2, Eun Joo Yun2.   

Abstract

BACKGROUND: The early and accurate detection of local or regional recurrence of head and neck tumor is critically important.
PURPOSE: To compare the diagnostic accuracy of contrast-enhanced computed tomography (CT), contrast-enhanced magnetic resonance imaging (MRI), and fluorodeoxyglucose (FDG) positron emission tomography (PET)-CT, alone and in combination, in detecting the locoregional recurrence of malignant head and neck tumor.
MATERIAL AND METHODS: A total of 93 patients with loco-regional recurrence of malignant head and neck tumors underwent CT, MRI, and PET-CT within 30 days before surgery. CT, MRI, and PET-CT for each patient were retrospectively reviewed to determine the presence of recurrent tumors in the primary site on a patient-by-patient basis and that of regional lymph nodes on a level-by-level basis. The diagnostic accuracy of CT, MRI, and PET-CT, alone and combined, were accessed with the postoperative histopathological findings or with 12-month follow-up results as the standard of reference.
RESULTS: The sensitivity/specificity/and accuracy of CT, MRI, and PET-CT for the detection of primary site recurrence was 89.9/85.7/89.3%, 94.9/85.7/93.6%, and 97.5/92.9/96.8%, respectively. The sensitivity/specificity/accuracy of CT, MRI, and PET-CT for the detection of nodal recurrence was 66.3/99.4/92.4%, 74.7/99.4/94.2%, and 85.5/94.9/93.0%, respectively. MRI + PET-CT achieved the best performance in the receiver operating characteristics curve analysis (Az value = 0.958 for primary site recurrence and 0.929 for nodal recurrence).
CONCLUSION: MRI + PET-CT offered the highest diagnostic performance in the detection of loco-regional recurrence of malignant head and neck tumor, compared with CT, MRI, PET-CT, and other combinations including CT.

Entities:  

Keywords:  Head and neck neoplasm; PET/CT; computed tomography (CT); magnetic resonance imaging (MRI); recurrence

Mesh:

Substances:

Year:  2018        PMID: 29754496     DOI: 10.1177/0284185118776504

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  1 in total

1.  Predictive Value of Early Post-Treatment Diffusion-Weighted MRI for Recurrence or Tumor Progression of Head and Neck Squamous Cell Carcinoma Treated with Chemo-Radiotherapy.

Authors:  Esteban Brenet; Coralie Barbe; Christine Hoeffel; Xavier Dubernard; Jean-Claude Merol; Léa Fath; Stéphanie Servagi-Vernat; Marc Labrousse
Journal:  Cancers (Basel)       Date:  2020-05-14       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.